Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Brown & Brown's second-quarter 2026 headline growth remained strong, with total revenue up 30.4% and adjusted EBITDAC up 27.0%, supported substantially by acquisitions. Underlying performance was less compelling: consolidated Organic Revenue declined 0.7%, Specialty Distribution Organic Revenue declined 3.5%, and adjusted EBITDAC margin fell to 35.7% from 36.7%. Organic Revenue with Contingents remained positive at 0.7%, and adjusted diluted earnings per share increased to $1.07. The resulting view is balanced: Accession provides greater scale and potential integration benefits, but evidence of durable organic-growth recovery and margin stabilization is needed.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets16 analysts · as of 18 Aug 2026
Low · most bearish analyst$56.00
Mean target$76.44
High · most bullish analyst$90.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$56.0026%

Organic weakness persists for multiple quarters, catastrophe-property pricing pressure continues in Specialty Distribution, and integration or technology spending prevents anticipated operating leverage. Higher acquisition-related debt and interest expense would then reduce flexibility.

Base CaseCentral scenario
$76.4456%
Matches the consensus mean

Acquisition-driven revenue and adjusted earnings growth continue, but organic growth recovers only gradually and the adjusted EBITDAC margin remains near its second-quarter 2026 level while Accession is integrated. This is the modal scenario.

Bull CaseUpside scenario
$90.0018%

Accession integration benefits and expense leverage materialize while consolidated and Specialty Distribution organic growth return to positive territory. Continued favorable contingent commissions and successful retention of acquired customer relationships support renewed margin expansion.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 total revenue increased 30.4% and adjusted EBITDAC increased 27.0%, demonstrating substantial post-Accession scale and continued adjusted earnings growth.
  • Organic Revenue with Contingents remained positive at 0.7%, while adjusted diluted net income per share increased 3.9% to $1.07.
Sign in / Sign up to read more
Key Investment Risks
  • Consolidated Organic Revenue declined 0.7%, and Specialty Distribution Organic Revenue declined 3.5% in the second quarter of 2026.
  • Adjusted EBITDAC margin declined to 35.7% from 36.7%, leaving execution and integration costs important determinants of future operating leverage.
  • The Accession transaction increased indebtedness and interest expense; the second-quarter filing reported $7.759 billion of total debt and $100 million of quarterly interest expense.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.